This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Randall Lipps Chairman, President, CEO, and Founder, Omnicell Today, I was excited to join thousands of registrants representing pharmacy, nursing, informatics, and healthcare leaders for the launch of Omnicell Illuminate 2020 , one of the year’s biggest digital events dedicated to technology-driven medication management.
Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. million preventable adverse drug events a year , resulting in $5.1 An ISMP Pulse Check of Sterile Compounding Practices” as part of Omnicell Illuminate 2020.
Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.
Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.
Jim Longo Senior Manager, Value Management, Omnicell Today’s healthcare environment is highly unpredictable. The ongoing effects of increasing expenses, downward pressure on revenue and reimbursement, and compressed operating margins are compounded by wildcards like the COVID-19 pandemic.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.
Ken Perez Vice President, Healthcare Policy, Omnicell Overreliance on manual processes and siloed technology in pharmacy operations are among the biggest challenges facing health systems today. The goal of this industry movement is to achieve zero-error medication management, while freeing pharmacists to practice at the top of their license.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content